Kewaunee Scientific Balance Sheet Health
Financial Health criteria checks 5/6
Kewaunee Scientific has a total shareholder equity of $45.3M and total debt of $31.5M, which brings its debt-to-equity ratio to 69.4%. Its total assets and total liabilities are $126.3M and $81.0M respectively. Kewaunee Scientific's EBIT is $15.3M making its interest coverage ratio 8.7. It has cash and short-term investments of $21.3M.
Key information
69.4%
Debt to equity ratio
US$31.48m
Debt
Interest coverage ratio | 8.7x |
Cash | US$21.31m |
Equity | US$45.34m |
Total liabilities | US$80.96m |
Total assets | US$126.31m |
Recent financial health updates
Kewaunee Scientific (NASDAQ:KEQU) Has A Somewhat Strained Balance Sheet
Mar 10Is Kewaunee Scientific (NASDAQ:KEQU) Weighed On By Its Debt Load?
Apr 12Here's Why Kewaunee Scientific (NASDAQ:KEQU) Can Afford Some Debt
Dec 28Recent updates
Even With A 26% Surge, Cautious Investors Are Not Rewarding Kewaunee Scientific Corporation's (NASDAQ:KEQU) Performance Completely
Dec 18Investors Could Be Concerned With Kewaunee Scientific's (NASDAQ:KEQU) Returns On Capital
Jul 02Kewaunee Scientific (NASDAQ:KEQU) Has A Somewhat Strained Balance Sheet
Mar 10Kewaunee Scientific GAAP EPS of -$0.27, revenue of $50.12M
Sep 08Kewaunee Scientific GAAP EPS of -$0.13, revenue of $49.72M
Jun 30Is Kewaunee Scientific (NASDAQ:KEQU) Weighed On By Its Debt Load?
Apr 12Here's Why Kewaunee Scientific (NASDAQ:KEQU) Can Afford Some Debt
Dec 28Kewaunee Scientific reports Q2 results
Dec 09Financial Position Analysis
Short Term Liabilities: KEQU's short term assets ($96.2M) exceed its short term liabilities ($42.1M).
Long Term Liabilities: KEQU's short term assets ($96.2M) exceed its long term liabilities ($38.8M).
Debt to Equity History and Analysis
Debt Level: KEQU's net debt to equity ratio (22.4%) is considered satisfactory.
Reducing Debt: KEQU's debt to equity ratio has increased from 13.8% to 69.4% over the past 5 years.
Debt Coverage: KEQU's debt is well covered by operating cash flow (57.7%).
Interest Coverage: KEQU's interest payments on its debt are well covered by EBIT (8.7x coverage).